AIDP Inc., the exclusive distributor of Magtein™ magnesium L-threonate, recognized as the next breakthrough ingredient for cognitive health, has announced it has been granted U.S. patent for Magtein’s unique magnesium compositions and its use for magnesium-containing food compositions (Patent 8,178,132).
The patent, titled “Magnesium-containing food compositions” is the first U.S. patent awarded from seven ongoing patent applications, including international rights for magnesium L-threonate. This first awarded patent protects Magtein’s unique magnesium compositions and its use for any magnesium L-threonate-containing food compositions. This encompassing broad stroke patent covers all food and beverage formats.
“We truly believe Magtein is a game changing ingredient that will benefit millions of busy and stressed consumers by helping to improve their quality of life,” says Edward Lee Ph.D., AIDP president.
“AIDP, as the exclusive supplier of Magtein magnesium L-threonate, is uniquely positioned to serve the functional food and beverage marketplaces to support the cognitive health category,” added Dr. Lee.
Discovered by Guosong Liu, M.D., Ph.D., and a group of distinguished scientists at Massachusetts Institute of Technology (MIT) and Tsinghua University in Beijing, China, studies on Magtein have been published in prestigious journals of neuroscience – Neuron (January 2010) and The Journal of Neuroscience (October 2011). With cognitive diseases the seventh leading cause of death in the U.S. and growing at an alarming rate, Magtein, which has self-affirmed GRAS status, is the only form of magnesium proven to significantly increase brain magnesium levels. Furthermore, animal research showed Magtein improved short-term and long-term memory as well as spatial recognition.